Today's Industry Symposia
6 – 7 a.m.
ALECENSA: The First and Only Adjuvant Treatment for Patients with Resectable ALK + NSCLC
Room 515A
Sponsored by Genentech
What you need to know for mitral valve lifetime management. Durability, hemodynamics and the MITRIS RESILIA valve.
Room 502A
Sponsored by Edwards Lifesciences
When Every Second Counts: The Latest Data and Expert Guidance on Antiplatelet Therapy Reversal for Surgical Professionals
Room 515B
Sponsored by Clinical Care Options
11:55 a.m. – 12:55 p.m.
The Next Generation of ATAD Repair: AMDS Hybrid Prosthesis World-wide Experience and Update on PERSEVERE IDE Study Results
Room 150
Sponsored by Artivion
Connecting the latest data to the first pre-assembled aortic valve conduit. KONECT device. Ready to implant. Learn the techniques.
Room 502A
Sponsored by Edwards Lifesciences
Optimizing The Care Pathway For Younger Patients – The Role of Mechanical Valves in the TAVR Era
Room 151
Sponsored by Abbott
Perioperative Immunotherapy + Neoadjuvant Platinum-Containing Chemotherapy for the Treatment of Resectable NSCLC
Room 515B
Sponsored by AstraZeneca
Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR & ALK TKI Therapy
Room 502B
Sponsored by PeerView
5:15 – 6:30 p.m.
Comprehensive Solution for Cardiac Procedures
Mastro's Ocean Club
Sponsored by Zimmer Biomet
5:45 – 6:45 p.m.
Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice
JW Marriott LA Live, Gold Ballroom 3
Sponsored by PeerView
